Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Current Deferred Tax Assets (2020 - 2023)

Historic Current Deferred Tax Assets for Universe Pharmaceuticals (UPC) over the last 2 years, with Q1 2022 value amounting to $7.6 million.

  • Universe Pharmaceuticals' Current Deferred Tax Assets changed N/A to $7.6 million in Q1 2022 from the same period last year, while for Mar 2022 it was $7.6 million, marking a year-over-year change of. This contributed to the annual value of $7.5 million for FY2021, which is N/A changed from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Current Deferred Tax Assets of $7.6 million as of Q1 2022.
  • In the past 5 years, Universe Pharmaceuticals' Current Deferred Tax Assets ranged from a high of $7.6 million in Q1 2022 and a low of $7.5 million during Q3 2021